Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib exploratory study in seasonal allergic rhinitis after repeated nasal allergen challenge
2006-004722-82Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of imatinib in seasonal allergic rhinitis (SAR) (2 arms), sponsored by Novartis. Primary endpoint: Reduction in mast cell degranulation after allergen challenge. Started Nov 2006; status: completed.
02
Drugs
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2006-004722-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004722-82.